| Literature DB >> 35964333 |
Yusuke Seino1, Nobuo Sato1, Masafumi Idei1,2, Takeshi Nomura1.
Abstract
BACKGROUND: Although the various advantages of clinical information systems in intensive care units (ICUs), such as intensive care information systems (ICISs), have been reported, their role in preventing medical errors remains unclear.Entities:
Keywords: clinical information system; electronic medical record; intensive care unit; medical error
Year: 2022 PMID: 35964333 PMCID: PMC9475405 DOI: 10.2196/39782
Source DB: PubMed Journal: JMIR Perioper Med ISSN: 2561-9128
Figure 1Workflow in the study period before ICIS implementation (April 1, 2018, to September 30, 2018). CPOE: computerized physician order entry; CRRT: continuous renal replacement therapy; EMR: electronic medical record; ICIS: intensive care information system; MCS: mechanical circulatory support.
Figure 2Workflow in the study period after the completion of a step-by-step implementation of ICIS (April 1, 2019, to September 30, 2019). CPOE: computerized physician order entry; CRRT: continuous renal replacement therapy; EMR: electronic medical record; ICIS: intensive care information system; MCS: mechanical circulatory support. *The patients’ basic profiles are sent from the EMR to the ICIS, except for information on their allergies and contraindications. **Blood products, narcotics, and drugs that require approval or registration (broad-spectrum antibiotics, drugs for chemotherapy, and rarely used drugs) need to be ordered in both the EMR system and ICIS. Changes in the orders are not synchronized.
Classification of the type of errors recommended by the Japan Council for Quality Health Care.
| Type of errors | Description |
| Medication | Errors related to medication or blood transfusion |
| Line, tube, or drain | Errors related to lines (venous routes or catheters), tubes (endotracheal tube or nasogastric tube), and drain (drainage tube from body cavities or wounds) |
| Equipment/devices | Errors related to medical equipment and devices |
| Diagnostic testing | Errors related to laboratory and imaging tests |
| Therapeutic | Errors related to treatments or procedures |
| Nursing care | Errors related to nursing care |
| Miscellaneous | None of the above |
Classification of the level of severity and influence of errors recommended by the National University Hospital Council of Japan.
| Level | Continuity of injury | Severity of injury | Description (NCC MERPa Category) |
| 0 | None | N/Ab | Errors or malfunctions in medicines and medical devices occurred but did not reach the patient (B). |
| 1 | None | N/A | There was no actual harm to the patient (but there was a possibility of some influence) (C). |
| 2 | Transient | Mild | Treatment was not required (enhanced patient observation, mild change in vital signs, examination for confirmation of safety, etc) (D). |
| 3a | Transient | Moderate | A simple procedure or treatment was required (disinfection, poultice, skin suture, administration of analgesics) (E). |
| 3b | Transient | Severe | A substantial procedure or treatment was required (significant change in vital signs, use of mechanical ventilation, surgery, prolongation of hospital stay, hospitalization, fracture, etc.) (F). |
| 4a | Permanent | Mild-moderate | Permanent disability or sequelae remained without significant functional impairment or cosmetic problems (G or H). |
| 4b | Permanent | Moderate-severe | Permanent disability or sequelae remained with significant functional impairment or cosmetic problems (G or H). |
| 5 | Death | N/A | Death (excluding that due to the natural course of the underlying disease) (I). |
| Others | N/A | N/A | Errors to which the classification was not able to be applied. |
aNCC MERP: National Coordinating Council for Medication Error Reporting and Prevention.
bN/A: not applicable.
Demographic data of the intensive care unit.
|
| Apr-Sep 2018 | Apr-Sep 2019 | |||
| Patients admitted, n | 755 | 719 | N/Aa | ||
| Total length of stay (patient-days), n | 2828 | 2600 | N/A | ||
| Length of stay (days), median (IQR) | 1.6 (0.8-3.6) | 1.6 (0.9-3.0) | .24 | ||
|
| |||||
|
| Age (years), median (IQR) | 63 (47-74) | 64 (45-72) | .42 | |
|
| Male gender, n (%) | 434 (57.5) | 420 (58.4) | .76 | |
|
| .93 | ||||
|
| Asian-Japanese, n (%) | 747 (98.9) | 711 (98.9) |
| |
|
| Asian-other, n (%) | 4 (0.5) | 5 (0.7) |
| |
|
| White, n (%) | 2 (0.3) | 2 (0.3) |
| |
|
| Other, n (%) | 2 (0.3) | 2 (0.3) |
| |
|
| .49 | ||||
|
| Cardiovascular surgery, n (%) | 264 (35.0) | 268 (37.3) |
| |
|
| Neurosurgery, n (%) | 242 (32.1) | 196 (27.3) |
| |
|
| Gastrointestinal surgery, n (%) | 68 (9.0) | 65 (9.0) |
| |
|
| Thoracic surgery, n (%) | 80 (10.6) | 95 (13.0) |
| |
|
| Urology and renal transplantation, n (%) | 31 (4.1) | 30 (4.2) |
| |
|
| Endocrine surgery, n (%) | 5 (0.7) | 3 (0.4) |
| |
|
| Miscellaneous surgery, n (%) | 24 (3.2) | 19 (2.6) |
| |
|
| Medical, n (%) | 41 (5.4) | 43 (5.9) |
| |
aN/A: not applicable.
Errors in the periods of April 2018 to September 2018 and April 2019 to September 2019.
|
| Apr-Sep 2018 | Apr-Sep 2019 | ||||
| Total errors, n | 156 | 71 | N/Aa | |||
| Incidence rate of total errors, | 55.2 | 27.3 | <.001 | |||
|
| .18 | |||||
|
| Cardiovascular surgery | 59 (37.8) | 30 (42.3) |
| ||
|
| Neurosurgery | 25 (16.0) | 11 (15.5) |
| ||
|
| Gastrointestinal surgery | 25 (16.0) | 13 (18.3) |
| ||
|
| Thoracic surgery | 5 (3.2) | 0 (0.0) |
| ||
|
| Urology and renal transplantation | 6 (3.8) | 5 (7.0) |
| ||
|
| Endocrine surgery | 0 (0.0) | 0 (0.0) |
| ||
|
| Miscellaneous surgery | 1 (0.6) | 2 (2.8) |
| ||
|
| Medical | 34 (21.8) | 8 (11.3) |
| ||
|
| Nondepartment | 1 (0.6) | 2 (2.8) |
| ||
| ICISb-related errors, n (%) | N/A | 10 (14.1) | N/A | |||
| ICIS-related errors incidence rate, | N/A | 3.8 (1.8-7.1) | N/A | |||
aN/A: not applicable.
bICIS: intensive care information system.
Type of errors in periods of April 2018 to September 2018 and April 2019 to September 2019.
| Type of errors | Apr-Sep 2018 | Apr-Sep 2019 | ||||
|
| n (%) (N=156) | Incidence ratea | n (%) (N=71) | Incidence ratea |
| |
| Medication | 78 (50.0) | 27.5 (21.8-34.4) | 31 (43.7) | 11.9 (8.1-16.9) | <.001 | |
| Line, tube, or drain | 53 (34.0) | 18.7 (14.0-24.5) | 24 (33.8) | 9.2 (5.9-13.7) | .004 | |
| Equipment/devices | 11 (7.1) | 3.9 (1.9-7.0) | 4 (5.6) | 1.5 (0.4-3.9) | .12 | |
| Diagnostic testing | 6 (3.8) | 2.1 (0.8-4.6) | 1 (1.4) | 0.4 (0.01-2.1) | .13 | |
| Therapeutic | 1 (0.6) | 0.4 (0.01-2.0) | 3 (4.2) | 1.2 (0.2-3.4) | .36 | |
| Nursing care | 6 (3.8) | 2.1 (0.8-4.6) | 5 (7.0) | 1.9 (0.6-4.5) | >.99 | |
| Miscellaneous | 1 (0.6) | 0.4 (0.01-2.0) | 3 (4.2) | 1.2 (0.2-3.4) | .36 | |
aThe incidence rate of the type of errors is presented as events per 1000 patient-days and 95% CI.
Severity and influence level of errors in periods of April 2018 to September 2018 and April 2019 to September 2019.
| Level of errors | Apr-Sep 2018 | Apr-Sep 2019 | ||||
|
| n (%) (N=156) | Incidence ratea | n (%) (N = 71) | Incidence ratea |
| |
| Level 0 | 23 (14.7) | 8.1 (5.2-12.2) | 7 (9.9) | 2.7 (1.1-5.5) | .009 | |
| Level 1 | 44 (28.2) | 15.2 (11.3-20.9) | 26 (36.6) | 10.0 (6.5-14.7) | .07 | |
| Level 2 | 47 (30.1) | 16.6 (12.2-22.1) | 19 (26.8) | 7.3 (4.4-11.4) | .002 | |
| Level 3a | 33 (21.2) | 11.7 (8.0-16.4) | 14 (19.7) | 5.4 (2.9-9.0) | .01 | |
| Level 3b | 7 (4.5) | 2.5 (1.0-5.1) | 5 (7.0) | 1.9 (0.6-4.5) | .78 | |
| Level 4a | 0 (0.0) | 0 | 0 (0.0) | 0 | N/Ab | |
| Level 4b | 0 (0.0) | 0 | 0 (0.0) | 0 | N/A | |
| Level 5 | 0 (0.0) | 0 | 0 (0.0) | 0 | N/A | |
| Others | 2 (1.3) | 0.7 (0.09-2.6) | 0 (0.0) | 0 | N/A | |
aThe incidence rate of the level of errors is presented as events per 1000 patient-days and 95% CI.
bN/A: not applicable.